American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 467-474 , March 2009

Serum Fetuin A in Hemodialysis: A Link Between Derangement of Calcium-Phosphorus Homeostasis and Progression of Atherosclerosis?

  • Giovanni Pertosa, MD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy
    • Corresponding Author InformationAddress correspondence to Giovanni Pertosa, MD, Renal, Dialysis and Transplant Unit, Department of Emergency and Transplantation, University of Bari, Piazza G. Cesare 11, 70124 Bari, Italy
    • ,
  • Simona Simone, MD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy
    • ,
  • Marco Ciccone, MD

      Affiliations

    • Department of Emergency and Transplantation, Division of Cardiology, University of Bari, Bari, Italy
    • ,
  • Silvia Porreca, MD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy
    • ,
  • Gianluigi Zaza, MD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy
    • ,
  • Giuseppe Dalfino, PhD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy
    • ,
  • Bruno Memoli, MD

      Affiliations

    • Division of Nephrology, University Federico II, Naples, Italy
    • ,
  • Alfredo Procino, PhD

      Affiliations

    • Division of Nephrology, University Federico II, Naples, Italy
    • ,
  • Mario Bonomini, MD

      Affiliations

    • Division of Nephrology, University G. D'Annunzio, Chieti, Italy
    • ,
  • Vittorio Sirolli, MD

      Affiliations

    • Division of Nephrology, University G. D'Annunzio, Chieti, Italy
    • ,
  • Giuseppe Castellano, MD, PhD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy
    • ,
  • Loreto Gesualdo, MD

      Affiliations

    • Department of Biomedical Sciences, Division of Nephrology, University of Foggia, Foggia, Italy
    • ,
  • Maria Ktena, MD

      Affiliations

    • Department of Biomedical Sciences, Division of Nephrology, University of Foggia, Foggia, Italy
    • ,
  • Francesco Paolo Schena, MD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy
    • ,
  • Giuseppe Grandaliano, MD

      Affiliations

    • Nephrology, Dialysis, and Transplantation Unit, University of Bari, Bari, Italy

Received 12 February 2008 ,Accepted 21 October 2008.

References 

  1. Foley RN, Parfrey PS, Sarak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis. 1998;32(suppl 5):S112–S119
  2. London GM. Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol. 2003;14(suppl 4):S305–S309
  3. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of CRP and risk of ischemic stroke and transient ischemic attack: The Framingham Study. Stroke. 2001;32:2575–2579
  4. Albert C, Ma J, Rifai N, et al. Prospective study of CRP, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105:2574–2576
  5. Moe SM, Reslerova M, Ketteler M, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. 2005;67:2295–2304
  6. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet. 2003;361:827–833
  7. Hermans MMH, Brandenburg V, Ketteler M, et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int. 2007;72:202–207
  8. Heiss A, DuChesne A, Denecke B, et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A (Formation of colloidal calciprotein particles). J Biol Chem. 2003;278:13333–13341
  9. de Groot E, van Leuven SI, Duivenvoorden R, et al. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med. 2008;5:280–288
  10. O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992;23:1752–1760
  11. Zoccali C, Benedetto FA, Maas R, et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol. 2002;13:490–496
  12. Nishizawa Y, Shoji T, Maekawa K, et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2003;41(suppl 1):S76–S79
  13. Wang TJ, Larson MG, Levy D, et al. C-Reactive protein is associated with subclinical epicardial coronary calcification in men and women: The Framingham Heart Study. Circulation. 2002;106:1189–1191
  14. Lebreton JP, Joisel F, Raoult JP, et al. Serum concentration of human α2HS glycoprotein during inflammatory process (Evidence that α2HS glycoprotein is a negative acute-phase reactant). J Clin Invest. 1978;64:1118–1129
  15. Memoli B, Bartolo L, Favia P, et al. Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor. Biomaterials. 2007;28:4836–4844
  16. Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20:1676–1685
  17. Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005;67:2383–2392
  18. Benedetto FA, Mallamaci F, Tripepi G, et al. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol. 2001;12:2458–2464
  19. Mathews ST, Singh GP, Ranalletta M, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002;51:2450–2458
  20. Haasemann M, Nawratil P, Muller-Esterl W. Rat tyrosine kinase inhibitor shows sequence similarity to human alpha 2-HS glycoprotein and bovine fetuin. Biochem J. 1991;274:899–902
  21. Heldin CH. Signal transduction: Multiple pathways, multiple options for treatment. Stem Cells. 2001;19:295–303
  22. Levitzki A. PDGF receptor tyrosine kinase inhibitors for the treatment of restenosis. Cardiovasc Res. 2005;65:581–586
  23. Clemmons DR. Modifying IGF-1 activity: An approach to treat endocrine diseases, atherosclerosis and cancer. Nat Rev Drug Discov. 2007;6:821–833
  24. Szweras M, Liu D, Partridge EA, et al. Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem. 2002;277:19991–19997
  25. Singh NN, Ramji DP. The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev. 2006;17:487–499
  26. Mehrotra R. Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease. Kidney Int. 2007;72:137–140
  27. Price PA, Lim JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin–mineral complex. J Biol Chem. 2003;278:22144–22152

 Originally published online as doi:10.1053/j.ajkd.2008.10.046 on January 27, 2009.

PII: S0272-6386(08)01683-1

doi: 10.1053/j.ajkd.2008.10.046

American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 467-474 , March 2009

Article Tools

* Image Usage & Resolution